Anthony Tumber
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 34
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 39
- Histone Deacetylase Inhibitors Research 24
- Cancer-related gene regulation 17
- Protein Degradation and Inhibitors 9
- RNA modifications and cancer 9
- Bone Metabolism and Diseases 7
- Hematology top 5%
- Oncology top 5%
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 9
- Co-authors
- Christopher J. SchofieldPeter A. HillMurray C. MeikleUdo OppermannAkane KawamuraLennart BrewitzJames W.A. RitchieLaura S. Collins
- Journals
- Journal of Medicinal Chemistry (11 papers)ChemMedChem (8 papers)Chemical Communications (6 papers)
- Partner nations
- United KingdomUnited StatesJapan
In The Last Decade
Anthony Tumber
94 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 676
- Molecular Biology 2.9k
- Hematology 267
- Oncology 584
- Biochemistry 123
Countries citing papers authored by Anthony Tumber
This map shows the geographic impact of Anthony Tumber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Tumber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Tumber more than expected).
Fields of papers citing papers by Anthony Tumber
This network shows the impact of papers produced by Anthony Tumber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Tumber. The network helps show where Anthony Tumber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anthony Tumber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 12 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 12 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 20 | |
| 10 | 2022 | 23 | |
| 11 | 2021 | 23 | |
| 12 | 2021 | 1 | |
| 13 | 2021 | 23 | |
| 14 | 2021 | 32 | |
| 15 | 2021 | 15 | |
| 16 | 2020 | 35 | |
| 17 | 2020 | 18 | |
| 18 | 2020 | 13 | |
| 19 | 2018 | 2 | |
| 20 | 2017 | 1 |
About Anthony Tumber
Anthony Tumber is a scholar working on Cancer Research, Biochemistry, Molecular Biology, Pharmacology and Hematology, having authored 95 papers that have together received 3.6k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (39 papers), Cancer, Hypoxia, and Metabolism (34 papers), Histone Deacetylase Inhibitors Research (24 papers), Cancer-related gene regulation (17 papers), Eicosanoids and Hypertension Pharmacology (9 papers), Protein Degradation and Inhibitors (9 papers), RNA modifications and cancer (9 papers) and Bone Metabolism and Diseases (7 papers). The work is most often cited by research in Cancer Research (676 citations), Molecular Biology (2.9k citations), Hematology (267 citations), Oncology (584 citations) and Biochemistry (123 citations). Anthony Tumber has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Christopher J. Schofield, Peter A. Hill, Murray C. Meikle, Udo Oppermann, Akane Kawamura, Lennart Brewitz, James W.A. Ritchie, Laura S. Collins, Maxwell Sehested and Paul E. Brennan. Their work appears in journals such as Journal of Medicinal Chemistry, ChemMedChem, Chemical Communications, Angewandte Chemie International Edition and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.